We studied 241 patients with non small cell bronchogenic cancer who were treated with cisplatin and etoposide or cisplatin, etoposide and vindesine. There were 11 (4.5%) complete responders in these series most of whom had a prolonged survival.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Aisner J, Hansen H H: Current status of chemotherapy for non small cell lung cancer.Cancer Treat Rep 65, 979 (1981).
Gralla R J, Casper E S, Kelsen D Tet al: Cisplatin and vindesine combination chemotherapy for advance carcinoma of the lung: a randomized trial investigating two dosage schedules.Ann Intern Med 95, 414 (1981).
Longeval E, Klastersky J and the E.O.R.T.C. Lung Cancer Working Party Belgium: Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma.Cancer 50, 2751 (1982).
Klastersky J, Sculier J P, Nicaise Cet al: Combination chemotherapy with cisplatin, etoposide and vindesine in non small cell lung carcinoma: a clinical trial of the EORTC Lung Cancer Working Party.Cancer Treat Rep 67, 727 (1983).
WHO-EORTC-NCI Meeting for Standardization of Results of Cancer Treatment (Brussels, 1979); published by WHO.
Casper E S, Gralla R J, Kelsen D P, Golbey R B: Complete responses of non small cell lung carcinoma to combination chemotherapy. In:Abstracts of the Third World Conference on Lung Cancer, May, 1982.
About this article
Cite this article
Klastersky, J., Sculier, J.P. & Mommen, P. Complete remissions in non small cell lung cancer. Med. Oncol. & Tumor Pharmacother. 2, 11–15 (1985). https://doi.org/10.1007/BF02934775
- Complete remission
- Lung cancer
- Non small cell carcinoma